Skip to content
★ Sign in to follow
DW

David W. Raisbeck

Board Director
Director
Total declarations
43
Companies
2
▲ Purchases (1 ops.)
€869k
▼ Sales (7 ops.)
€2.6M

Latest filing published 15 May 2024 for Eastman Chemical Co, €1.3M.

Filing timeline

BuySale
David W. Raisbeck

Insider track record

Disclosed buys
1
Disclosed sells
7
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 10 Dec 2018 · 2890 days ago · €869k
    +6.2%
    Entry US$72.55 · Close at T+365 US$77.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David W. Raisbeck: trading record in brief

This profile gathers the share dealings of David W. Raisbeck across 2 companies, led by Eastman Chemical Co and Cardinal Health Inc. Over a trading history stretching from 4 May 2006 to 14 May 2024, the count stands at 43 filings.

In open-market terms, that means 1 purchase worth €869k on one side and 7 sales worth €2.6M on the other. The net balance comes to €1.7M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 27 share grants and 8 option exercises. 2024 to date brings no purchases and 1 sale.

The newest entry dates from 15 May 2024: an open-market sale of €1.3M, in Eastman Chemical Co. The most recent open-market purchase was published on 10 December 2018, 2,890 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to David W. Raisbeck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations41 total

25 of 41 declarations